MEDNAX Announces Acquisition of Pediatric Ophthalmology Practice in Washington
Children’s Eye Care was established in 2008 and employs two
ophthalmologists, one optometrist and eight full-time non-clinical
associates. The practice provides pediatric eye care, full surgical
services and retinopathy of prematurity (ROP) evaluation and treatment,
including laser ablation and Avastin® therapy. It also offers an on-site
optical shop. Children’s Eye Care has one patient office and provides
services to four regional hospitals, including Swedish Medical Center’s
First Hill and Issaquah Campuses,
“Given the changing medical environment, partnering with the
This acquisition adds to the services
This was a cash transaction and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.
With this acquisition, three physician group practices have become part
of
ABOUT
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
View source version on businesswire.com: https://www.businesswire.com/news/home/20180321005179/en/
Source:
MEDNAX, Inc.
Charles Lynch, 954-384-0175, ext. 5692
Vice
President, Strategy and Investor Relations
charles_lynch@mednax.com